Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of AK102 administered every 6 weeks in patients with hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia [Phase 3]
Phase 3 trial evaluating the efficacy and safety of AK102 in patients with hyperlipidemia has completed.
-
CLINICAL_TRIALS withdrawal · 2025-03-06Clinical Trial Update: Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency
A clinical trial evaluating how cholesterol levels affect long-term patency of coronary artery bypass grafts has been withdrawn; the study i…
-
FDA label_change · 2025-03-03FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for simvastatin from Accord Healthcare, Inc., under the ANDA process, likely affecting labeling.
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: Cardiovascular Risk Screening and Risk Reduction in Women Vets [NA]
Completed results from a clinical trial on cardiovascular risk screening and risk reduction in women veterans; results were posted on 2025-0…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia [Phase 3]
This clinical trial update reports a Phase 3 study evaluating the long-term efficacy and safety of AK102 in patients with hyperlipidemia, co…
-
FDA approval · 2025-02-24FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for pravastatin sodium from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2025-02-24FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pravastatin sodium submitted by Aurobindo Pharma Limited. This action pertains to the generic pr…
-
FDA approval · 2025-02-18FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Quallent)
FDA approved a supplemental application for Pravastatin Sodium submitted by Quallent, indicating an approved change to the product under an …
-
FDA label_change · 2025-02-12FDA Approved: EZALLOR SPRINKLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for EZALLOR SPRINKLE (rosuvastatin) to support the sprinkle dosage-form labeling. This action expand…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: To Understand the Self-care Ability of Farmers and Fishermen With CMDs (Hypertension, Heart Disease, Hyperlipidemia, Type 2 Diabetes), Whether They Are Aware of CMDs, Their Treatment Status, Treatment Effectiveness, and Their Ability to Describe Known and Practice the Self-care Content of CMDs. [NA]
A clinical trial sponsored by Chang Gung Memorial Hospital is recruiting to assess self-care ability, disease awareness, treatment status, a…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Evaluation of the Effects of Two Dietary Supplement Formulations on the Lipid Profile in Mild Hypercholesterolemia [NA]
A clinical trial is evaluating two dietary supplement formulations for their effect on lipid profiles in adults with mild hypercholesterolem…
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Community Intervention to Improve CVD Risk Factor Control in Young American Indians [NA]
Clinical trial update for a community intervention to improve cardiovascular risk factor control (cholesterol and diabetes) among young Amer…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of pitavastatin in combination with PCSK9 inhibitors in liver transplant pa…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine [Phase 2, Phase 3]
This entry notes an ongoing Phase 2/3 clinical trial evaluating berberine for sex-specific lipid- and lipoprotein-lowering effects in indivi…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid [Phase 3]
A phase 3 clinical trial update evaluating the efficacy, tolerability, and safety of bempedoic acid for primary hyperlipidemia, sponsored by…
-
FDA approval · 2025-01-14FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for rosuvastatin calcium submitted by Sun Pharmaceutical Industries, Inc., approving an additional f…
-
FDA approval · 2025-01-14FDA Approved: ROSUVASTATIN — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for rosuvastatin submitted by ScieGen Pharmaceuticals, enabling the marketing of a generic rosuv…
-
FDA approval · 2025-01-14FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Rosuvastatin Calcium from Ascend Laboratories, LLC, supporting the continued availability of a r…
-
FDA approval · 2025-01-14FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Umedica Laboratories USA Inc.)
The FDA granted supplemental approval for rosuvastatin calcium under an ANDA for Umedica Laboratories USA Inc., confirming the generic produ…
-
FDA approval · 2025-01-10FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s supplemental application for atorvastatin calcium, authorizing its continued marketing as a generic statin…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Determining the Lipid Lowering Effect of Fenugreek Seed Tea [NA]
A completed clinical trial evaluating whether fenugreek seed tea lowers lipid levels in individuals with hyperlipidemia.
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients with Hyperlipidemia [NA]
A clinical trial sponsored by Peking Union Medical College Hospital is evaluating the effects of omega-3 polyunsaturated fatty acids on lipi…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Telenhealth and Adherence to Stains [NA]
Assiut University completed a clinical trial evaluating telehealth to improve adherence to lipid-lowering medications (statins).
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol [Phase 2]
This entry covers a Phase 2 clinical trial of QLC7401 for primary hypercholesterolemia or mixed hyperlipidemia with elevated LDL, which is n…